Metrizoic Acid

Metrizoic acid is a molecule used as a contrast medium. It present a higher risk of allergic reactions due to its high osmolality. Its approval has been discontinued by the FDA. One study in 1976 demonstrated that metrizoic acid, when used for cardiac angiography, was well tolerated. A total of 10, 000 injections were administered to 2,028 patients undergoing angiocardiographic procedures over a three-year period. With two exceptions, all complications occurred during injection of the right coronary artery. Seven cases of ventricular fibrillation, and 5 of significant bradycardia/asystole, were associated with metrizoic acid injection. In general, the drug was well tolerated by patients during cardiac examinations. It is grouped under the following drug class(es): CT contrast agents. Its therapeutic use is listed as diagnostic agents. The directory classifies it as a discontinued API with a synthetic source/manufacturing origin. Other names for this substance include Acide metrizoique and Acidum metrizoicum. Its PubChem CID is 2528.

CAS No 1949-45-7
Molecular Formula C12H11I3N2O4
Molecular Weight 627.94 g/mol
Synonyms 3-acetamido-5-[acetyl(methyl)amino]-2,4,6-triiodobenzoic acid

Frequently Asked Questions